概念词典 · 方法论
隐形冠军
在产业链某个细分环节占据绝对统治地位、但行业外几乎无人知晓的小公司——Serenity 整套研究方法的核心目标。
别名： 隐形冠军／ hidden champion／ 卡点／ 上游卡点／ chokepoint
是什么
“隐形冠军” 这个词源自德国管理学者 Hermann Simon 对德国中小企业的研究。Serenity 借用它来描述他寻找投资标的的核心目标：
在 AI 算力扩张这条产业链上，哪一个细分环节产能跟不上，而做这环节的公司又恰好小到没被大基金覆盖——这就是值得重仓的隐形冠军。
三个判断维度
他在多条推文里阐述过他的筛选框架：
1. BOM 占比
拆开终端产品的物料清单 (Bill of Materials)，看这个公司的零件在总成本里占多大比例。比例越高、可替代性越低 → 定价权越强。
“$VPG 很可能在特斯拉 Optimus 的 BOM 占据极高份额”
2. 产能弹性差
“短缺时无法快速扩产”是隐形冠军的护城河。精密齿轮、化合物半导体衬底、特种激光器晶圆——这些环节扩产周期 18-36 个月。
3. 客户集中但不被替代
看似风险（客户高度集中）实际是壁垒：一旦被设计进客户的 BOM 就很难被换掉，因为重新认证成本高。
与”卡点 / chokepoint”的关系
“卡点”是 Serenity 自创的更口语化表达，含义和”隐形冠军”几乎一致。本站站名 「上游卡点」 也来自这个概念。
顺着供应链向上游走，找到那个没人盯着的卡点。
典型隐形冠军案例
| 公司 | 卡的什么 |
|---|---|
| $AXTI | InP 衬底（全球前三） |
| $SIVE | DFB/CW 激光器（CPO 必备） |
| $VPG | 应变片（人形机器人感知层） |
| 绿的谐波 | 谐波减速器（机器人关节） |
| IntelliEPI | InP 外延（衬底下游一环） |
反例：不是隐形冠军
他常用 “Fake it Until you make it” 标记一类自称隐形冠军但财务证据不足的公司：
- $POET：宣传 CPO 但实际产品和营收脱节
- $IREN：宣传 AI 数据中心但实质仍是矿机
提到此概念的推文 (123)
按时间倒序 · 滚到底自动加载更多
-
看好AAOI 2027年表现及AXTI衬底瓶颈，提示短期抛压与稀释风险。
@DZMakeMoney 我无法就人们应如何处理交易提供建议。就个人而言，我认为 $AAOI 在 2027 年将表现优异，且 $AXTI 的磷化铟(InP)衬底瓶颈/卡脖子环节已得到验证。对于 AXT 而言，更多取决于其与 $LITE 和 $COHR 等协议带来的平均售价(ASP)提升。AXT 近期因宏观因素受高贝塔 AI 板块抛售的负面影响。AOI 有一笔令人失望的 6 亿美元可转换优先股(ATM)发行，造成大量短期压力。但这不影响其 2027 年光模块(transceiver)需求可见度，且他们应很快完成 1.6T 认证。过去两个月出现大幅回调，但取决于你发现什么有吸引力，也有许多机会。
英文原文
@DZMakeMoney I can’t give advice over what people should do with their trades. Personally speaking, I think $AAOI outperforms in 2027 and the $AXTI InP substrates bottleneck/chokepoint got validated. With AXT it’s more of a matter of ASP hikes moving forward with their agreements like $LITE and $COHR. AXT is negatively affected by high beta AI sector selloff recently with macro. AOI has a very disappointing $600m ATM so that’s a lot of near term overhang. But doesn’t affect their 2027 transceiver demand visibility and they should finish 1.6T qualifications soon. Past 2 month has seen major corrections, but there’s a lot of opportunity too depending on what you find compelling
-
无视宏观波动，因AI资本支出强劲且需求失衡，坚持做多AI核心标的。
宏观环境显然在过去几个月削减了高贝塔AI的估值。但我试图专注于基本面。 如果你好奇我的看法： 我们看到了创纪录的长期协议(LTA)可见性： - 存储(至2031年)、光子学(至2029-2030年)等 - $NBIS、$SOL等，尽管资本支出巨大，但算力需求仍存在巨大失衡。 - 加上创纪录的预测（$NVDA 2027年增长70%，$SMCI新增服务器订单超600亿美元等）。 对比： 令人不安的宏观环境： - 沃什表示，如果核心通胀未明确回归2%，美联储“还有更多工作要做”。 - 7月PCE同比为3.7% - 7月就业报告新增就业减少2.3万，失业率4.1% - 10年期美债收益率高企/30年期创2007年以来新高 - 伊朗紧张局势持续 - 日元跌至160/韩国两次加息 且近期加息25个基点的概率为40/60。 这肯定会对融资产生影响，且第三/四阶效应太多，我个人无法完全映射。 我不是宏观专家，但我的看法是： AI建设将继续，预计明年上游投入超1.3万亿美元资本支出，流经许多瓶颈和卡点。 虽然市场削减了远期估值并转向当前盈利/防御性公司。 我不知道会发生什么，尤其是加息概率几乎五五开，且特朗普的帖子可能一夜之间改变情绪。 只要我没看到超大规模云厂商削减资本支出或需求波动的迹象。 尽管宏观波动，我保持做多，因为我想持有控制AI建设未来格局的公司。 如果宏观环境有任何好转迹象，高贝塔股通常恢复最快。
英文原文
Macro has clearly cut high beta AI valuations over the past few months. But I try to stay focused on fundamentals. If you're curious about my take though: We're seeing record visibility with - memory (2031), photonics (2029-2030), etc LTAs - $NBIS, solana:5aQcoaSyy7fnhvpRHasBUAMH2nL5tTjVrmFw6BeGmoon, etc. massive demand imbalance for compute despite capex spend. - combined with record projections ( $NVDA 70% growth 2027, $SMCI $60B+ new server orders, etc). vs. uncomfortable macro where: - Warsh said the Fed has "more work to do" if underlying inflation isn't clearly returning to 2%. - July PCE came in at 3.7% Y/Y - July jobs report payrolls fell by 23k with unemployment at 4.1% -10Y Treasury high/ 30Y highest since 2007 - Iran tensions continuing - Japan Yen weakened to 160/ 2 rate hikes in Korea And with rate 40/60 in favor of 25BPS near-term hikes. There's definitely implications on financing + too many third/fourth order effects for me to personally map. I'm not a macro expert but my take is: The AI buildout will continue w/ $1.3T+ capex poured upstream expected next year, flowing through many bottlenecks and chokepoints. While markets chopped off forward valuations and rotated toward currently profitable/defensive companies. I don't know what's going to happen, especially since rate hike odds are almost a coinflip, and Trump posts can change sentiment overnight. As long as I don't see indicators of hyperscalers cutting capex or demand wavering. I'm staying long despite macro volatility, since I want ownership of the names controlling the future of the AI buildout. And if there's any indicators of better macro climates, high beta are typically the fastest to recover.
-
博主庆祝瓶颈论点获验证，硅光子普及促成多项新产能协议。
@AizuddinAl4653 这需要你自己估算！我不想给出市值(MC)估算，尤其是当人们可能会误解模型时。我只是在庆祝“瓶颈(chokepoint)”论点得到了外部评论的验证，这些评论提到了类似垄断的市场份额数据。而且，由于硅光子(silicon photonics)的大规模采用，这一瓶颈已经转化为可能带来10多项新长期协议(LTAs)/产能协议。
英文原文
@AizuddinAl4653 That’s for you to estimate yourself! I don’t want to give MC estimates especially if people misinterpret the modeling I’m just celebrating that the chokepoint thesis was validated by external commentary around monopoly-like market share figures. And since the chokepoint converted into likely 10+ new LTAs/capacity agreements because of siph mass adoption.
-
Soitec 产能协议进展顺利，硅光子衬底垄断地位确立。
还记得我关于 $SOI 的论点吗？Soitec 今天的采访评论： - 预计 1-2 周内将敲定 80% 的产能预留协议，总数超过 10 份。 - $2 亿的光子学-SOI 营收现在被描述为“绝对底线”。 $TSM 也认为硅光子集成 (SiPH) 将在 2027 年成为主流，市场份额将超过光收发器市场的 50%+。 如果你在一个瓶颈环节占据垄断地位： （瑞银估计 Soitec 在支撑硅光子芯片的衬底市场占据 95% 份额） 收入通常会流经你。
英文原文
Remember my $SOI thesis anon? Soitec interview commentary today: - 80% of capacity reservation agreements expected within 1-2 weeks, with more than 10 in total. - $200M Photonics-SOI revenue now described as "absolutely a floor" $TSM also sees SiPH going mainstream in 2027 with market share topping 50%+ of the optical transceiver market If you hold a monopoly-like position over a chokepoint: (UBS estimates Soitec has 95% share of the market for substrates underpinning silicon photonics chips) Revenue usually flows through you.
-
NVDA指引超预期，AI供应链瓶颈环节将迎来爆发。
提醒AI看空者：$NVDA 预测2027年超大规模云厂商支出将达1.3万亿美元。较2026年约8000亿美元大幅增长，尽管产能仍受限，营收增速仍达约70%，远超华尔街此前约45%的预期。这些资本支出流向AI供应链……从存储、网络到晶圆代工厂。尤其是那些未从旧世代中受益的新瓶颈/卡点环节。我们就像派对刚开始2小时，大家起初喝的是札幌生啤。有人往情境(Situational)的酒里加了烈酒，我们不得不暂停派对30分钟。但现在派对重启，桌上摆满了龙舌兰酒。我认为真正的狂欢即将开始。
英文原文
FYI to the AI bears: $NVDA projects $1.3T of hyperscaler spend for 2027. Up from ~$800B in 2026, alongside ~70% revenue growth despite remaining capacity constrained… far above prior Street expectations of ~45%. That capex flows across the AI supply chain… from memory and networking to foundries. Especially through the new bottlenecks/chokepoints that didn’t benefit from older generations. We’re like 2 hours into the party where people started off drinking Sapporo draft beer. Someone spiked Situational’s drinks and we had to pause the party for 30 min. But now it’s back on with tequila shots on the table. I think the real party is about to begin.
-
SIVE受CW激光瓶颈利好，有望从瓶颈供应商成长为光学巨头。
@wannabepanacea 目前我所见的是由沟通失误和噪音引发的市场波动。论点破位的情况会是：1. 晶圆代工产能分配出现问题，因为这会影响供应。（但他们现在有两家）。2. 或者资格认证失败。（他们发出了上半年 $JBL 订单的信号，但还需观察）。从根本上说，我认为在 CW 激光（连续波激光）瓶颈期间，$SIVE 处于绝佳位置。我也看到 Sivers 有潜力成为更大的光学巨头，而不仅仅是关键的瓶颈供应商……这就是为什么我更关注公司的方向。
英文原文
@wannabepanacea So far, what I've seen is market volatility stemming from communication failures and noise. Thesis break would be 1. issues with their foundry allocations, since that would affect supply. (But they have 2 now). 2. Or failing qualifications. (they signaled $JBL orders for H1, but we'll see). Fundamentally I think $SIVE is in an amazing spot during a CW laser bottleneck. I also see more potential for Sivers to become a larger optical giant rather than remain just a chokepoint supplier... which is why I focus on company direction a lot more.
-
AXTI虽证实瓶颈地位，但需极高ASP才能支撑高估值，合同细节待观察。
@he8496 $AXTI 需要将磷化铟(InP)基板的平均售价(ASP)提高到内存级别的极端水平，才能实现进一步的重估，例如达到 2000-3000 亿美元的估值。我认为瓶颈已得到证实，其卡脖子地位也已得到证实。然而，我不清楚其与 $LITE 和 $COHR 的合同或长期协议(LTA)具体包含什么内容。随着时间推移我们会看到结果（披露* 持有 AXT 股份）。
英文原文
@he8496 $AXTI would need to hike ASPs of InP substrates to extreme levels you see in memory to see further rerating eg. $20-30B valuations. I think the bottleneck is proven, their chokepoint is proven. However, I don't know what the contracts or LTAs with $LITE and $COHR entail. We'll find out over time (disclosure* own AXT shares).
-
批评 $SIVE 财报沟通保守，建议激进并购与双重上市以加速扩张。
如果我要批评 $SIVE 的财报： 1. 管理层低估了两个最重要的披露事项。 -> 6 个可插拔模块(Pluggable)的合作项目 -> 晶圆代工产能(Foundry capacity)（正值行业瓶颈期） 这是电话会议最重要的部分，本应重点阐述其经济规模。但我们只听到了2-3句话。 而且，不应该让 X 上的动漫头像来主要谈论这些影响。 2. CFO 需要重新培训或换人。 作为股东，听到律师式的回答令人愤怒。连我都对这句话感到恼火： “我们将评估时机，并决定是否在条件成熟时推进。” 现在他们申请双重上市以逃离充满敌意的瑞典市场，这应该是板上钉钉的事。 股东资助一家未来增长型公司，不是为了听律师式的回答。 再次强调，这可能是 CFO 给出的最糟糕的回答之一，需要坚定的承诺和更快的时间表。 3. 7000万美元应用于并购和双重上市。 -> 坦白说，现阶段专注于混合制造(Hybrid manufacturing)是资本浪费，听到这个我很失望。 虽然最终需要，但已有2家晶圆代工供应商。 -> 你拥有大量新资本和庞大的市值。 利用它进行类似 $AVGO 风格的收购，获取 Cloud Light 类的可插拔模块或光引擎(Optical engines)知识产权。 Lumilens 在2年内从0增长到55亿美元，现在已与超大规模云服务商合作。 Sivers 应尽快摆脱激光瓶颈，不要只做组件供应商。 最重要的是，谁在乎与客户竞争？如果客户说：“如果你做可插拔模块，我们将转向其他供应商购买激光”， 谁会？$LITE / $COHR / $AAOI 将激光转向内部使用。许多亚洲玩家已分配完毕。 尽可能利用当前的瓶颈，因为几乎没有合格的替代选择。 我确信所有合作伙伴都试图向上垂直整合到激光层级并进行竞争。 如果在 Q2 期间尝试了新的光引擎/可插拔模块收购，情况会大不相同。 _ TLDR： $SIVE 应旨在成为下一个 $LITE，像硅谷公司一样闪电扩张。 利用那7000万美元资本在下半年(H2)加速，至少完成准备。并预计纳斯达克上市在 2027 年上半年完成。 而不是那个时间段的“评估”。 并利用资本+股权向下扩展到光引擎/ELS/光收发器，使用你的股权估值，收购 Celestial/Ayar/Cloud Lite 类初创公司。 至于电话会议的措辞，市场关心的是晶圆代工分配+6家可插拔模块玩家的经济价值，而不是其他业务部门。 $SIVE 迄今为止极其保守，但 他们需要加速并向面向未来的美国/国际股东沟通。 而不是面向关心 Q2/滚动十二个月(TTM)收入的当地瑞典受众。 否则他们将被视为亚洲组件供应商，并最终被估值为欧洲公司。
英文原文
If I had to be critical of $SIVE earnings: 1. Management underweighted the two disclosures that matter most. -> 6 pluggable engagements -> Foundry capacity (during an industry bottleneck) That's the most important part of the call and should have been the focus to provide economic scale of them. But we got 2-3 sentences about it. And it shouldn't take an Anime avatar on X to talk most about the implications of those. 2. CFO needs retraining or bring on a new one. The lawyer like answers were infuriating to listen to as a shareholder. Even I got pissed off with this statement: "we will evaluate the timing and decide whether the conditions are right to move forward at that particular time." It should be a 100% given by now they file for dual listing to escape hostile Swedish markets. Shareholders didn't fund a future growth type company to hear lawyer-like answers. Again, this was probably one of the worst answers the CFO could have gave and there needs to be firm commitment along with faster timelines. 3. $70M should have gone toward M&A and dual listing. -> Brutally honestly speaking, it's a waste of capital to focus on hybrid manufacturing at this stage and I was disappointed to hear this during this timeframe. It's eventually needed but with 2 foundry suppliers -> You have a ton of new capital and large marketcap. Use it to pull $AVGO style acquisitions of Cloud Light style IP for pluggables or optical engines. Lumilens went from 0 -> $5.5B in 2 years and now with hyperscaler engagements. Sivers should expand out of the laser chokepoint as fast as possible and not stay just a component vendor. And most of all, who cares about competing with customers? If a customer says: "if you do pluggables, we'll go with other players for lasers" who?? $LITE / $COHR / $AAOI reroutes their lasers to internal usage. Lot of your Asian players already allocated. Abuse the current bottleneck as much as possible because there's almost no qualified choices left. And I'm certain all the partners are trying to vertically integrate upward toward the laser level too and compete. If there was a new OE/pluggable accusation attempted during the Q2 time frame, things would have been a lot different. _ TLDR: $SIVE should aim to be the next $LITE and blitzscale like a Silicon Valley company. Use that $70m capital to move faster H2, and at the bare minimum finish readiness then. And expect NASDAQ listing to be finished H1 2027. Not "evaluation" at that timeframe. And use the capital + equity to expand downward into optical engines/ELS/optical transceivers using your equity valuation, and buy a Celestial/Ayar/Cloud Lite type startup. As for the wording of the call, markets care about economic value of the foundry allocation + 6 pluggable players, not other business segments. $SIVE has been extremely conservative to date, but they need to speed up and communicate to forward looking US/Int shareholders. Not geared toward local Swedish audiences who care about Q2/TTM revenue. Otherwise they'll be treated like an Asian component supplier and eventually be valued like an EU one.
-
博主回应中国粉丝为其AI瓶颈投资法命名的趣事。
@Benedict542440 我是说，我的中国粉丝群显然给我的 AI 瓶颈投资风格起了个专属名字。 “紫苏叶理论”，也就是“Perilla Leaf Theory”/“Shiso Leaf Theory”，所以我会说差不多对吧？ https://t.co/cy44L7WPrW
英文原文
@Benedict542440 I mean my Chinese fanbase gave my AI chokepoint investing style its own name apparently. 紫苏叶理论”, the “Perilla Leaf Theory” / “Shiso Leaf Theory”, so I’ll say close enough? https://t.co/cy44L7WPrW
-
IQE论点获验证，债务清零且获大厂订单，作者继续持有看多。
感觉今年2月我对 $IQE 的论点连同 $AXTI 等一起得到了验证。（我目前仍持有两者的多头头寸） 所以我减少了对它们的覆盖。但简而言之，更新如下： 今年早些时候，当我发布关于它的论点时，IQE 是光学供应链中一个陷入困境但关键的瓶颈环节，与 $LITE 等公司有关联。 自那以来： - $MTSI 签署了长期外延晶圆供应协议，并入股该公司，现在 IQE 已无银行债务（Macom 有可转债，但这是积极的） - $TSEM 签署了磷化铟(InP)外延晶圆协议。 - 管理层明确表示，其与 IQE 的协议是为了确保“该路线图所需的战略性 III-V 族外延晶圆供应” - IQE 签署了另一份约1400万美元的神秘 AI 数据中心合同。 我早期论点中仍在展开的部分是 IQE 将其潜在/未充分利用的产能转向 AI 数据中心领域，以匹配该领域的同行如 Landmark（这需要时间，如果我没记错的话，略多于一年的时间）。 还有一些国家安全层面的含义，我将避免谈论，但这使它们更加重要。 但基本上： 2025财年营收：9730万英镑 2026财年指引：超过1.265亿英镑 它们在光学领域再次快速增长，摆脱了银行债务/困境清算状态，并仍然是西方光学供应链中的关键瓶颈。 现在……随着与领先光子学公司的新协议带来营收增长，以及像 Macom 这样的玩家充当软性后盾。 通常在论点得到验证后，我只是坐享企业的增长。
英文原文
Feels like my $IQE thesis Feb this year got validated alongside $AXTI and others. (I still long on both) So I stopped covering them as much. But TLDR on updates: Early this year, IQE was a distressed but critical chokepoint in the optical supply chain with links to $LITE and others when I published my thesis on it. Since then: - $MTSI signed long term epiwafer supply agreements, took a stake in the company, now IQE is bank debt free (Macom has convertibles, but that's positive) - $TSEM signed agreements for InP epiwafers. - Management explicitly said its IQE agreement was signed to secure the "strategic III-V epiwafer supply required for that roadmap" - IQE signed another ~$14M mysterious AI DC contract. The only part that's still playing out with my earlier thesis is IQE converting their latent/underutilized capacity toward AI DC segment, to match peers like Landmark in the space (which takes time, like slightly over a year if I remember correctly). There's some national security implications that I'll avoid talking about that makes them more important. But basically: FY2025 revenue: £97.3m FY2026 guidance: over £126.5m They're rapidly growing again in the optical sector, out of bank debt/distressed liquidation state, and remains a critical chokepoint in Western optical supply chains. Now... with new agreements with your leading photonics companies for revenue growth, and players like Macom serving as a soft backstop. After a thesis gets validated, typically I just sit back and enjoy growth of a business.
-
SIVE有望复刻LITE路径，需并购及纳斯达克上市以扩大规模。
@Berlinergy 我说 $LITE 在2-3年内从30亿增长到600亿+，尤其是由于2023年底收购Cloud Light，使总可寻址市场(TAM)扩大了5倍以上。因为他们最初是从EML激光器/光组件的瓶颈环节起步的，后来通过并购发展。$SIVE 有潜力从CW激光器瓶颈环节起步，实现同样的增长。但这需要类似在可插拔模块或光引擎/ELS方面进行成功的并购。如果它们想达到类似的规模，就需要从像 $AAOI 这样的成品光模块中获取更多收入。而我的观点是，纳斯达克上市对于解锁更多资金来实现这一点是必要的。
英文原文
@Berlinergy I said $LITE went from $3b to $60B+ over a 2-3 year timeframe, especially due from Cloud Light acquisition in late 2023, that multiplied TAM by 5x+. Since they started off in the EML laser / optical component chokepoint originally before M&A. $SIVE has the potential to do the same starting off in the CW laser chokepoint. But it does require something like a successful M&A down pluggables or optical engines/ELS. To capture more revenue off things like completed transceivers $AAOI, if they want to get to a similar scale. And my take was NASDAQ listing is necessary to unlock more funding to do so.
-
光通信财报验证CW激光器瓶颈，SIVE作为稀缺CPO标的获看好。
这就是我目前看到的关于 $SIVE 和连续波(Continuous Wave, CW)分布反馈(DFB)激光器瓶颈的情况。 来自光通信板块的财报： 1. $LITE：UHP CW 激光器出现意外需求和供需失衡。 - 有能力提高激光器的平均售价(ASP)。 - 共封装光学(CPO)扩产按计划进行，预计2027年下半年出货，称任何关于CPO扩产延迟的谣言都是噪音。 Lumentum 确认了时间表（此前 Sivers 因误导性报告被抛售），高利润率，以及经过认证的CW激光器需求极度旺盛。 2. $AAOI：由于光模块需求过大，CW 激光器产能不足。 - 并未实质性参与第一代 CPO 部署，$MTSI 看起来也不在其中，专注于非平面光学(NPO)。在 $SMTC 收购 HieFo 后，我没看到太多动静。 - 称激光器是光模块20-40%需求失衡中的瓶颈。 - 称客户每周都来找他们要求供货并加快进度。 AOI 确认了需求失衡 + 激光器瓶颈。第一代 CPO 玩家池子更小。 3. $AAOI 和 $LITE 均称中国玩家在 CPO 激光器方面落后数年，且实际认证产能远落后于其声称。 - $AAOI 称落后2-3年以上。 - $LITE 称未见到如中方声称那样的产出（若虚假也无追责手段）。 重申了 CPO 相关激光器的护城河，光通信板块并未如某些空头声称的那样被中国产品淹没。 4. $MTSI 称许多客户因磷化铟(InP) DFB 激光器普遍短缺而紧急接触他们。 再次将 Sivers 置于该瓶颈中，使其可能获得更多客户需求。 在 $COHR ($725.4亿市值)、$LITE ($665.7亿市值)、$AVGO ($2.13万亿市值) 中： 能以约 $15亿市值获得西方四大 CPO 领导者之一的 $SIVE，非常特别。 感觉我的论点得到了验证： - 我预测的 CW 瓶颈 - CW 激光器瓶颈（至少对于第一代而言，只有少数 CPO 玩家） 现在只需等待下一代光架构转变的拐点。
英文原文
So this is just what I'm seeing with $SIVE and the CW DFB laser chokepoint right now. From optical earnings: 1. $LITE: unexpected demand and imbalance for UHP CW lasers. - Had ability to price up ASP for lasers. - Scale up CPO on track for H2 2027 shipments, called out any CPO scale up delay rumors as noise. Lumentum confirmed timelines (that CPO players like Sivers sold off of misleading reports from), high margins, and extreme demand for qualified CW lasers. 2. $AAOI: doesn’t have enough CW laser capacity because of too much optical transceiver demand. - Not meaningfully participating in first-gen CPO deployments, with $MTSI not looking like they're in it either but focusing on NPO. Haven't seen much with $SMTC after their HieFo acqusition. - Called lasers as the bottleneck within a 20-40% demand imbalance for transceivers. - Says customers approaching them every week asking them for supply + to move faster. AOI confirmed demand imbalances + bottlenecks for lasers. And we got an even smaller pool for first-gen CPO players. 3. Both $AAOI and $LITE claimed Chinese players were years behind for CPO lasers and far behind stated claims in qualified capacity. - $AAOI said 2-3 years+ behind with CPO lasers. - $LITE said they haven't seen anything like Chinese claims in terms of outputs (and no recourse if it's false). Reaffirms moat for CPO related lasers, and no flooding from some shortseller claims on the optical sector. 4. $MTSI said that many customers are approaching them with urgency due to the general supply shortage of indium phosphide DFB lasers. Again, puts Sivers in the that bottleneck, giving them likely more customer demand . Among $COHR ($72.54B), $LITE ($66.57B), $AVGO ($2.13T): It's very special you get one of the public 4 Western CPO leaders at a ~$1.5B MC with $SIVE. Feels like my thesis with both: - The CW bottleneck that I predicted - CW laser chokepoint (where there's only a few CPO players, at least for gen-1) Got validated from earnings, now it's just waiting for the inflection points of next optical architecture shifts.
-
LITE财报证实CPO 27H2放量，CW激光供需失衡且中国厂商落后。
$LITE 财报电话会要点： - “我们对共封装光学(CPO)规模化部署的时间表可见度已提高。我们确信，2027年下半年我们的超高功率激光芯片需求将强劲增长。” Lumentum 确认其领先客户将于 2027 年下半年启动 CPO 规模化放量。 - “我们最近获得了首个外部光源(ELS)模块订单，将于 2027 年下半年交付。” ELS 行业放量时间表。 - “非平面光学(NPO)机会对我们完全是增量，显著增加了光学市场的总规模(TAM)。” 激光瓶颈俱乐部的 TAM 进一步扩大。 - “我们预计 1.6T 光模块的采用将从财年第一季度开始加速，并持续至 2027 年。” - “即使在连续波(CW)激光领域，我们对自己提价的能力也感到惊讶。” $SIVE 及其他 CW 激光玩家拥有积极的定价权。 - “因此，我们能够获得可观的价格溢价，并预计这种溢价将维持下去，即使这些中国厂商上线。我也提醒人们，我认为一些中国激光供应商目前并未在市场上实际交付，所以当它们抛出那些大数字时，没有追索权。迄今为止，我们在其产出方面尚未看到类似情况。” 中国厂商在激光/产能方面落后于市场预期，得到 $AAOI 和 $LITE 的证实。 - “不幸的是，我们在高功率激光的发货上远远落后。” “需求信号增加，相对于我们的供应能力，我们更加落后。” 超高功率(UHP) CW 激光产能存在极端供需失衡，EML 需求持续失衡。年底发货约 +5000 万美元 -> 1 亿美元+（“三位数季度”），进入 2027 年下半年和 2028 年更大的规模化需求。 - “所以，我认为过去三个月我们真正试图做的是确保更多的衬底供应”（因为供需失衡），“我们从 $AXTI 找到了额外的衬底帮助。他们是伟大的合作伙伴。” 磷化铟(InP)衬底瓶颈出现。 要点总结： - Lumentum 确认 CPO 2027 年下半年放量，驳斥任何“延迟”新闻为市场“噪音”。（一份延迟报告造成了巨大损害，Nvidia、Lumentum 等公司花了数周进行危机公关）。 - CW 激光需求在 2027 年下半年放量。 - 超高功率 CW 激光产能的极端供需失衡让 Lumentum 感到惊讶。 - 超高功率激光拥有极高利润率，并能对 CW 激光产能提价。 - 中国在激光/产能方面进一步落后。 基本上验证了西方 CW 激光玩家的时间表 + 需求/定价。 在主要放量开始之前，CW 激光的稀缺性已经发生……
英文原文
$LITE earnings transcript TLDRs: - "Our visibility into the timing of CPO scale-up deployments has also sharpened. We remain confident in a demand ramp for our ultra-high-power laser chips in the second half of calendar 2027" H2 2027 start of CPO scale up ramp confirmed from Lumentum for their lead customer. - "We were recently given our first external light source, or ELS, module purchase for delivery by the second half of calendar 2027" ELS industry ramp timelines - "The NPO opportunity is completely additive for us, significantly increasing the optical TAM." More TAM for laser chokepoint club - "we expect the 1.6T transceiver uptake to intensify starting in fiscal Q1 and sustain through calendar 2027." - "Even in CW, we’ve been surprised at our ability to price up" Positive pricing power for $SIVE and the other CW laser players. - "As a result, we are able to command a nice price premium that we expect to sustain, as these Chinese if these Chinese guys come online. I caution people also, I think people are some of these Chinese laser suppliers are not delivering in the market today, so they have there is no recourse when they throw out these big numbers. We have not seen anything like that to date in terms of their output." Chinese players are more behind than markets expect, corroborated by $AAOI and $LITE. - "We are way behind in our shipments, unfortunately, on high-powered lasers" "The demand signal has increased, and we are very much further behind relative to our ability to supply." Extreme demand imbalance for UHP CW laser capacity, continued demand imbalance for EML. Shipping roughly +$50M year end -> $100m+ ("triple digit quarter") into much larger H2 2027 and 2028 scale up demand,. - "So what we are trying to do, I think, really in the last three months is secure even more substrate supply" (because of demand imbalance), "we found additional substrate help from $AXTI They are a great partner." Hello InP substrate bottleneck. TLDR: - Lumentum CPO scale up H2 2027 shipments got confirmed, dismissed any "delay" news as market "noise". (one delay report caused so much damage, and it took Nvidia, Lumentum, and all these companies weeks to do damage control). - CW lasers demand ramp second half of 2027 - Extreme demand imbalance for UHP CW laser capacity surprised Lumentum - UHP lasers commands very high margins and is able to price up CW laser capacity. - China further behind in the laser/capacity angle. Basically just validated timelines + demand/pricing for Western CW laser players. CW laser scarcity is already happening before the main volume ramp even begins...
-
SIVE撤回收购案，从激光瓶颈扩大TAM，博主预期更高。
@softmaxedx 这只是激光阵列产能建模。看多逻辑是 $SIVE 撤回其 Cloud Light 收购案，并从激光瓶颈处扩大总可寻址市场(TAM)。我个人预期更高，但大家可以自行估值。
英文原文
@softmaxedx This is just laser array capacity modeling. The bull case is $SIVE pulling their own Cloud Light acquisition and multiplying TAM starting from the laser chokepoint. I have much higher expectations personally, but people can make their own valuation estimates. https://t.co/sS372W0SYR
-
AAOI财报揭示CPO激光器产能瓶颈，利好少数西方厂商，中国技术落后数年。
哇，$AAOI 的财报中对于 $SIVE 及其他激光器玩家来说，利好一个接一个。 1. $AAOI 并未实质性参与第一代共封装光学(CPO)部署。 “我们根本无法生产足够的[CPO激光器]来参与他们当前的一代[CPO]部署，因为产能根本不够。我们必须优先保障自有光模块的激光器供应。” 因此，第一代CPO激光器的部署范围可能会进一步缩小，仅限于$SIVE、$LITE、$AVGO和$COHR等西方厂商。 如果$AAOI不得不拒绝更多客户，独立的CPO连续波(CW)激光器产能将变得更有价值。 还要记得Trendforce曾提到$AMD签署了CW长期协议(LTA)？$COHR/$LITE已与$NVDA签署了产能协议…… 我原以为是$AAOI，但他们可能出局了。$MTSI在早期CPO参与中也不显眼（除了NPO外财报未提及，且从Ayar网站移除）。 所以我在想$AMD在Helios项目中会与谁合作（例如Sivers+Ayar现在更可能是候选者）？ 顺便说一句，这对$AAOI并非看空，因为他们光模块业务需求旺盛。只是对少数有产能的合格CPO激光器厂商更加看多。 2. 磷化铟(InP)激光器/光模块的需求失衡与瓶颈。 AOI CEO的话某种程度上证实了这一点：“客户需求比扩建后的产能高出20%-40%。” “我们几乎每周都从几家大客户那里收到这种需求。激光器目前是光模块业务最大的瓶颈。” 3. 中国在CPO波分复用(DWDM)规格激光器方面落后数年。 我之前在渠道调研CPO竞争时曾覆盖过这一点。 但$AAOI确认中国“至少落后两三年甚至更久”才能拥有CPO激光器，这极大地印证了西方激光器在CPO激光器卡脖子环节上的防御性地位。 总结： - CW激光器和光模块需求严重失衡。 - $AAOI因产能限制未进入第一代CPO（对$AAOI不算看空，因其光模块需求旺盛，但对$SIVE等少数有产能的独立厂商更是利好）。 - 中国在CPO激光器方面落后数年。
英文原文
Wow, there's gem after gem in $AAOI earnings for $SIVE + other laser player readthrough. 1. AAOI not meaningfully participating in CPO first-gen deployments. "We just can’t make enough of them [CPO lasers] to be involved in their current first-generation [CPO] deployments because there’s just not enough capacity. We have to prioritize our ability to make lasers for our own transceivers first" So first-gen CPO laser deployments, might even be narrowed down further for Western players like $SIVE, $LITE, $AVGO, and $COHR. And independent CPO CW laser capacity became more valuable if $AAOI had to turn away more customers... Also remember Trendforce was talking about $AMD singing CW LTAs? $COHR / $LITE have capacity signed with $NVDA ... I thought it would be $AAOI, but they might be out of the equation. $MTSI also doesn't look meaningful with early CPO participation (eg. no mention in ER aside from NPO, and removal from Ayar website). So I wonder who players like $AMD is going to go with for Helios (eg. Sivers + Ayar more likely candidate now)? Btw, this is not bearish AAOI because they have too much demand for optical transceiver business. Just more bullish on the existing few qualified CPO laser names that have capacity. 2. Demand imbalance and bottleneck for InP lasers / optical transceivers. AOI's CEO stated kinda supported that when they said: "The customer demand is 20%-40% higher" than expanded built out capacity. "We are getting this kind of demand from several big customers almost every week. Lasers are the biggest bottleneck right now for the transceiver business" 3. China being years away from having CPO DWDM specification lasers. I covered this earlier when looking at CPO competition from channel checks. But AAOI confirming that China is "easily at least two, three years or even longer from having CPO lasers is incredible tread through on defensibility Western laser positioning in the CPO laser chokepoint. TLDR: - High demand imbalance for CW lasers and optical transceivers. - $AAOI not in first-gen CPO due to capacity constraints (not exactly bearish AAOI because they have too much demand for their optical transciver business, but even better news for the few independent players with capacity coming online like $SIVE) - China years behind in CPO lasers.
-
AI激光器供应危机加剧，验证AAOI等标的瓶颈逻辑。
$LITE CEO Michael Hurlston 在 RAISE 峰会上警告称，AI 数据中心（AI DCs）用磷化铟(InP)激光器的供应缺口： 正面临比存储芯片更严重的供应链危机。 凭借 Lumentum 的 5 座 InP 晶圆厂，其出货量将比客户需求低 30% 以上。 这在目前的电吸收调制激光器(EMLs)上尤为明显，但随着共封装光学(CPO)的推进，已扩展至连续波(CW)激光器。 我一直看好 $AAOI、$SIVE、$LITE 和 $COHR 带来的激光器卡脖子+瓶颈逻辑。很高兴这一论点开始得到验证。
英文原文
$LITE CEO Michael Hurlston at the RAISE Summit warned that the supply gap for InP lasers for AI DCs: Is facing a more severe supply chain crisis than memory. And with Lumentum's 5 InP fabs, shipments would be more than 30%+ below customer demand. This is especially visible with EMLs today but is already expanding to CW, especially as CPO ramps. I've always been a fan of the laser chokepoint + bottleneck from $AAOI, $SIVE, $LITE, and $COHR. And glad this thesis is starting to see validation.
-
博主澄清CPO延迟谣言，认为亚洲股错杀，看好MSSCorp及早期受益股。
@Erick_P23 核心逻辑更偏向于共封装光学(CPO)的规模化，预计其复杂性将使MSSCorp成为检测良率方面的垄断型瓶颈（他们声称目标市场份额为90%）。尽管这些技术也可用于其他领域。 $FORM 的产能爬坡早了很多，所以下次财报中营收可能会开始显现？ 无论如何，亚洲概念股因CPO时间表延迟的报道而大幅抛售，但我通过$AMD 大会上的渠道核实发现该报道不实。 我认为我的观点没有改变，更多的是在等待2027年。 像Shunsin这样拥有更多确认的规模化交换机出货量，以及像 $AAOI / $SIVE 这样的激光概念股，其产能爬坡要早得多。在我看来，这只是时间线的问题，以及市场何时愿意对此进行定价。
英文原文
@Erick_P23 Thesis is more for CPO scale up expecting complexity making make MSSCorp a monopoly-type chokepoint over inspection yields (they were claiming 90% market share target). Although they can be used for other segments. $FORM ramped a lot earlier, so maybe will revenue would start to appear in next earnings? Regardless, Asian names sold off extremely hard on CPO timeline delay report that I found to be incorrect with my channel checks at the $AMD conference. Don't think my views have changed, it's moreso waiting for 2027. Names with more confirmed scale-out switch volumes like Shunsin + laser names like $AAOI / $SIVE ramp a lot earlier. It's just timelines in my view and when markets want to price that in.
-
类比LITE历史涨幅，看好SIVE凭借CPO技术主导新瓶颈环节。
@CArgyres29810 我认为人们往往忘记，$LITE 凭借对电吸收调制器(EML)瓶颈环节的控制，在两年内估值从 30 亿美元飙升至 600 亿美元以上。这发生在高盛预测到 2028 年下半年总可寻址市场(TAM)将 9 倍扩张至约 1540 亿美元之前。$SIVE 有机会凭借 1.6T 和共封装光学(CPO)技术主导下一个连续波(CW)瓶颈环节。而它目前的市值仅为约 11 亿美元。
英文原文
@CArgyres29810 I think people tend to forget that $LITE went from a $3B valuation to $60B+ in 2 years time from owning the EML chokepoint. This was before the 9x TAM expansion to ~$154B per GS by H2 2028. $SIVE has the opportunity to dominate the next CW chokepoint with 1.6T and CPO. And it's sitting at ~$1.1B now.
-
NVDA导致EML瓶颈迫使架构转向，IMO光子学及CW激光器成关键瓶颈。
集成模块光学(IMO)光子学主题+连续波(CW)激光器瓶颈是顶级的。市场真的像有短期记忆丧失症，忘了$LITE从2024年到现在是如何从30亿美元涨到650多亿美元的。因为$NVDA导致了外延激光管芯(EML)瓶颈，并迫使架构改变。我们实际上正在看到同样的情况
英文原文
IMO photonics theme + CW laser chokepoint is goated. It's legit like markets have short term memory loss and forgot how $LITE went from $3B -> $65B+ from 2024 to now. Because $NVDA caused EML bottlenecks, and forced architectural changes. We're literally seeing the same
-
LPK 玻璃基板设备具垄断优势，预计量产爬坡后市值可达 30-50 亿。
关于 $LPK：如果让我猜，当它们全面量产爬坡时，市值达到 30 亿至 50 亿美元似乎是合理的。 对我来说，这感觉更具非对称性，因为这只是一个等待游戏，而且它们已经拥有玻璃基板的客户。 小型设备供应商的瓶颈通常受限于总可寻址市场 (TAM)，除非你是 ASML 或像 KLAC 那样拥有多个瓶颈，否则很难达到 200 亿美元以上。 在全面量产爬坡前夕，很少有像这样占主导地位的“垄断者”： 也许你有类似： - Aixtron (MOCVD) ~80 亿美元 - Towa (压缩键合) ~20 亿美元 - Techwing (内存处理器/立方探针) ~15 亿美元 - MSScorps (CPO 检测)，但处于量产前阶段。8.5 亿美元 - Riber (量子分子束外延)，非常早期的量产前阶段 ~3.5 亿美元 然后是 LPK 激光用于玻璃核心基板（即将量产），市值约 7.3 亿美元，从主题上讲应该比内存享有更多溢价。（例如，主要先进封装转变，CPO 相关等）。 我知道很多晦涩的化学垄断者，但由于其物料清单 (BOM) 远低于设备，因此没有受到太多关注。 但对于 LPK 你有： 例如：“全球主要玩家中 80% 的客户选择了 LPKF 设备”。 在玻璃核心量产中，LIDE 市场份额目标为 70%，应该非常重要。（披露：持有，上述列出的名称中除了 Techwing/Aixtron 外，NFI）。 这只是如果你跟随 $AEHR 在约 35 亿美元时的路径： - <5 亿美元：“哦，他们没有客户！” --->（可能在这里的中间某处）。 - <15 亿美元：“也许很快就会有量！” - 30 亿美元及以上：“看起来他们开始全面量产爬坡了。” 这只是我个人经验中关于瓶颈设备供应商周期的一课。
英文原文
As for $LPK: Maybe $3B-$5B seems reasonable when they fully volume ramp if I had to guess. Feels more asymmetrical to me personally since it's just a waiting game and they have the customers for glass substrates. Small machine supplier chokepoints usually cap out from TAM though and don't go to $20B+ unless you're ASML or hold many chokepoints like KLAC. Not many dominant "monopolies" like these out there right before volume ramp this small: Maybe you have stuff like: - Aixtron (MOCVD) ~$8B - Towa (compression bonding) ~$2B - Techwing (memory handler/cube probes) ~$1.5B - MSScorps (CPO inspection), but pre-ramp. $850M - Riber (quantum MBE), very pre-ramp ~$350M Then LPK Laser for glass core substrates (about to ramp) at ~$730M, which thematically should have more premiums than memory. (eg. major advanced packaging shift, CPO adjacent, etc). Lot of obscure chemical monopolies I know of, but those don't get as much attention cause BOM is much lower than equipment. But for lpk you have: eg. “80% of customers among major global players have selected LPKF equipment”. 70% of LIDE market share target for TGV in the glass-core ramp, should be very material. (disclosure: own, the listed names above aside from techwing/aixtron, NFI). Just kinda the path they go if you follow $AEHR at ~$3.5B now: - <$500m: "Oh they have no customers!" ---> (probably somewhere in the middle here). - < $1.5B: "Maybe volume comes soon!" - $3B+ onward: "Looks like they're starting to volume ramp. Just a lesson for the cycle of the chokepoint machine suppliers from my personal experiences.
-
澄清误解，论证SIVE在CPO及可插拔光模块中的核心地位，强烈看多。
这是一个误解： $SIVE 是下一代架构的激光器供应商，不仅仅局限于共封装光学(CPO)的规模扩展(scale up)。 可插拔(Pluggable)、规模扩展(scale out) CPO、规模扩展(scale up) CPO、近封装光学(NPO)等。 - Sivers 和 $JBL 开启了“神模式”，开发了采用连续波(CW)激光器的 1.6T 光模块。 有效地绕过了电吸收调制激光器(EML)的瓶颈，甚至提高了能效。 根据捷普(Jabil)管理层的说法，他们建立了“相对显著的护城河”。 因此，对于下一代 1.6T 可插拔光模块，Sivers 似乎立即被采用。 市场也错过了这一细微差别：在捷普宣布后，其他可插拔厂商也主动联系，SIVE 现在正与他们合作（可能处于联合开发、资格认证阶段）。 像 Lumentum 这样垂直整合的光模块厂商并不多（想想中际旭创/新易盛，可能还有其他）。 所以这些是正在进行的开发，只是尚未公开披露，随时可能发布新的新闻稿。 - 对于 2026 年下半年开始的 CPO 规模扩展(scale out)，如 $POET，$SIVE 是这些厂商的激光器供应商。 - 规模扩展(scale up) CPO 将在 2027 年下半年到来，来自 Ayar 和英伟达(Nvidia)的 NVLink CPO 生态系统，这是光模块厂商的主要放量阶段。 但在这里，$SIVE 看起来在供应链映射中碾压其他所有玩家。 因为他们很可能早在规模尚小时就与 $MRVL Celestial、Lightmatter、Lightelligence 等合作并完成了设计导入。 除此之外还有： 对于像 $GFS 这样的晶圆代工厂，$SIVE 是参考激光器。 甚至不包括像 O-Net 这样与 $SIVE 合作构建 ELS 的大公司，可能用于亚洲超大规模数据中心的供应链。 这就是为什么 $SIVE 是我目前最看好的激光器瓶颈长持标的。 感觉从 2027 年初开始，他们在新的光学架构中无处不在。
英文原文
That’s a misconception: $SIVE is the laser supplier for next gen architectures, not just CPO scale up. Pluggable, scale out CPO, scale up CPO, NPO, etc. - Sivers and $JBL went god-mode and developed 1.6T optical transceivers with CW lasers. Effectively designing around the EML bottlenecks, and even made things more power efficient. From quotes from Jabil management they created a “relatively dramatic moat”. So for the next gen of 1.6T pluggable transceivers, Sivers seems immediately used. Markets missed this nuance too: after Jabil’s announcement, other pluggable players reached out, and SIVE is working with them now (prob codevelopment, qualification stage). There’s not too many players that build optical transceivers that aren’t vertically integrated like Lumentum (think: Innolight/eoptolink, and maybe others). So these are active developments, just not public material yet and could be a new press release anytime. - for CPO scale out which happens H2 2026 onward like $POET , $SIVE is a laser supplier for those players. - scale up CPO is h2 2027, from Ayar and Nvidia’a NVLink CPO ecosystem and that’s the main volume ramp across optical players. But this is where $SIVE looks like they mog every other player from supply chain mapping. Since they’ve likely been working + designed in with $MRVL Celestial, Lightmatter, Lightelligence and the others since they were small way back when. On top of things like this: For foundries like $GFS , $SIVE is the reference laser. Not even including massive companies like O-Net building ELS with $SIVE, likely for the Asian hyperscalers supply chains. This is why $SIVE is by far my favorite laser chokepoint long. Feels like they’re everywhere in new optical architectures starting beginning of 2027.
-
回顾核心欧洲多头持仓，重点解析Sivers在光子学领域的瓶颈地位。
简单回顾一下，以下是我所有的核心欧洲多头持仓： 1. $SIVE 2. $LPK 3. $SOI 4. $RPI 5. $IQE 6. $ALRIB 7. $XFAB Sivers：如你所知，它是下一代光子学的核心激光瓶颈环节，涵盖从1.6T可插拔光模块到共封装光学(CPO)。 嵌入在许多超大规模云计算服务商的供应商（如Jabil）中。
英文原文
Just as a recap, these were all my core European longs: 1. $SIVE 2. $LPK 3. $SOI 4. $RPI 5. $IQE 6. $ALRIB 7. $XFAB Sivers: As you know by now, core laser chokepoint over next generation photonics, from 1.6T pluggables to CPO. Embedded in many hyperscaler suppliers from Jabil
-
认为SIVE可能是明年CPO的关键瓶颈。
$SIVE 看起来像是明年 CPO 的关键 chokepoint 和 bottleneck。 我不断看到非技术人士发布的信息漏掉了所有细节。 原因如下： 1. $LITE 财报已经发出信号，CW 激光器存在瓶颈。 激光器晶圆厂产能大量分配给 EML……
英文原文
$SIVE looks like both a chokepoint and a bottleneck for CPO next year. Keep seeing information published from nontechnical people who miss any nuances. Here’s the reason why: 1. CW lasers are bottlenecked signaled by $LITE earnings. Laser fabs are heavily allocated to EML
-
称SIVE是最近最明显、仍在重估的CPO激光瓶颈。
回复 @_king142：$SIVE 可能是最近最明显、仍在重估中的激光器瓶颈，因为它似乎出现在每个 $NVDA NVLink CPO 生态伙伴以及 merchant/ASIC CPO 供应链里。 也许下一个是 CPO 中的无源光组件供应链。
英文原文
@_king142 $SIVE was probably the most recent visible laser chokepoint that’s still being rerated since seem to be in every $NVDA NVLink CPO ecosystem partner + merchant/asic cpo supply chains. Maybe passive optical components supply chains in CPO next.
-
暗示某光子学公司成为NVDA NVLink Fusion CPO生态上游激光瓶颈。
哇……今天发布了一个极具转折意义的新消息。 这让某家光子学公司成为： $NVDA NVLink Fusion CPO 生态的事实上的上游激光瓶颈。 它们的激光器现在进入了 Nvidia 的光基础设施供应链。 有人能猜到名字吗？
英文原文
Wow… new extremely transformative news got released today. Making a certain photonics company: The effective upstream laser chokepoint for $NVDA NVLink fusion CPO ecosystem. With their lasers now in Nvidia’s optical infrastructure supply chains. Can anyone guess the name?
-
SIVE作为光子学激光瓶颈，获GFS/JBL等公开验证。
-> IP 收购 -> 只是等待 CPO 起飞 $SIVE 是光子学的激光瓶颈，并已被公开验证： - $GFS（根据演示，是 CPO 两家公开激光供应商之一，另一家是 $LITE） - $JBL（与 Sivers 构建的可插拔产品拥有“相当显著的护城河”） -
英文原文
-> IP acquisition -> Just waiting for CPO to take off $SIVE is a laser chokepoint for photonics and are publicly validated by: - $GFS (1 of 2 public laser suppliers with $LITE for CPO per presentation) - $JBL (“Relatively dramatic moat” for pluggables built with Sivers) -
-
称自己的瓶颈投资理论可能被历史研究，涉及AXTI/SOI/SIVE。
我在想，我的瓶颈投资理论…… 从 $AXTI 到 $SOI 再到 $SIVE，将来会不会被写进历史书研究？ 无论如何，我认为这里的每个人都是创造历史的一部分。 因为从路透社到机构再到各国，都在对 Serenity 引发的供应链博弈论作出反应。
英文原文
I wonder if my chokepoint investment theory… With $AXTI to $SOI to $SIVE will be studied in future history books? Regardless, I think everyone here is a part of making history. Given Reuters to Institutions to Countries are reacting to supply chain game theory with Serenity.
-
长文重申SIVE是最有吸引力的CPO/光子学敞口，并列出客户、资金、上市和M&A催化。
$SIVE 是我眼中最有吸引力的 CPO/光子学敞口。 针对错误信息：我没有卖出，也不打算卖出一股。 我确实认为它有一天会从约21亿美元成长为下一个800亿美元以上的 $LITE。 我个人也计划获得更多所有权，并支持它们的并购前景。 我相信财报电话会记录会非常正面。 过去几个月我们发现了很多线索：AlChip/Amazon 私募对 Ayar 有利，并暗示 $SIVE 进入 Trainium 4 设计；Wiwynn + Ayar 的 CPO 放量；$JBL 1.6T 光收发器与 Sivers 的放量比市场预期更快；O-Net 正在扩大与 $SIVE 的 ELS 努力；$YSS 收购 $SIVE 的 allspace 主要合作伙伴并把 Sivers 设计进太空防务主承包商；新的 CHIPS Act 资金；$POET 下半年放量及其新订单（$SIVE 作为光源）；关于 $AAPL 使用 $SIVE 激光用于下一代消费设备的信息；与 Lightelligence、Lightmatter、Celestial/$MRVL、Lightium、$AMD/$GFS、Ayar、可插拔 TAM、NASDAQ 上市、MSCI/Nasdaq OMX 纳入、M&A、$NOK 客户线索、$LITE 的 CW 瓶颈和 Win 产能协议等信息。 这些市场研究都发生在财报之前。任何财报结果只是对供应链映射的确认。 我不认为有人关心前一季度收入，因为 $SIVE 是一个极具吸引力的2027年多头，尤其是下半年以后。 我只看几件事：整体光子学超级周期的 TAM 扩张（如光引擎、ELS、可插拔），来自并购或业务发展的机会；现有客户的放量预期；NASDAQ 上市时间线，以获得更多流动性支持并购；以及 CPO/可插拔的新客户信号。
英文原文
$SIVE is the most compelling CPO/photonics exposure to me. Addressing the disinformation: I haven’t sold and don’t plan to sell a single share. I do think this ends up the next $80B+ $LITE one day from ~$2.1B. And I personally have plans to acquire more ownership + support their M&A prospects. I believe earnings transcripts will be strongly positive. As in the part few months we’ve discovered: > AlChip/Amazon private placements, which is positive for Ayar -> $SIVE implying Trainium 4 design in > Wiwynn + Ayar CPO scale up > $JBL 1.6T optical transceiver ramp with Sivers incoming faster than markets expected (with relatively dramatic moat + demand as much as they can produce) > O-Net scaling up ELS efforts with $SIVE > $YSS acquisition of $SIVE allspace lead partner, designing Sivers into Space defense primes > New CHIPS ACT funding for $SIVE > $POET H2 volume ramp and their new $50m -> $500m order (with $SIVE as light source) > information discovery around $AAPL using $SIVE lasers for next gen consumer devices > information discovery around links to Lightelligence (went public $10B+ MC) + Lightmatter as likely customers. > Celestial volume ramp with $MRVL indicators. > new customers working on TFLN with $SIVE like Lightium > $AMD going with $GFS for CPO, and GFS listing sivers as one of two laser suppliers > Ayar removing $MTSI / $LITE from their website and signaling $SIVE as primary source/sole source > Ayar raising $500m for volume ramp (intel, Mediatek, Nvidia, amd etc) > pluggable TAM expansion signaled from 2025 annual report > Nasdaq listing expected soon > MSCI small cap index / Nasdaq omx inclusion, making Blackrock, Vanguard and others passive buyers > M&A signaled from 2025 annual report + 2 new board members that have experience in that area > $NOK as likely customer from 2025 annual report. > $LITE getting cw bottlenecked from EML contracts, $SIVE signaling capacity agreements in place with Win, making the a likely bottleneck owner + chokepoint in CPO sector. All of this market research was done before earnings. Any results is just confirmation of supply chain mapping done. I don’t think anyone cares about former quarter revenue since $SIVE is an exceptionally compelling 2027 long, especially H2 onward. Only thing I’m looking at are: > TAM expansion of the overall photonics supercycle (eg. optical engine, ELS, pluggables) either from M&A or developments > volume ramp expectations from existing companies > Nasdaq listing timelines for more liquidity to support their M&A efforts > any new customers signaled for CPO/Pluggables
-
用私有CPO玩家估值论证SIVE作为上游激光瓶颈应获得更高估值。
给试图做 $SIVE 估值分析的人： Ayar、Celestial、Lightmatter、Lightelligence 今天大概估值约40亿到150亿美元以上。 Sivers 市值约26亿美元，而且很可能是它们所有人的上游激光供应商。 我甚至还没把 Poet、TFLN 相关的 Hyperlight/Lightium，或 Jabil 和其他未披露可插拔玩家纳入估值分析。 也没包括 CHIPS Act 合同、Apple/Nokia 关系，或 Aeva 等人形/物理 AI 业务。 散户对私募市场不太熟悉……但这些公司都被视为前沿 CPO 玩家，并且估值和规模都在迅速增长。 所以我预计 $SIVE 应该获得类似甚至更高估值，因为它有激光瓶颈溢价。尤其是在它通过并购扩展 TAM 和收入之后。 下个月 BlackRock/Vanguard/MSCI/NASDAQ 新资金流入会随时间缩小差距。 但 NASDAQ 上市可能才是真正给 Sivers 溢价的因素。
英文原文
For people trying to do valuation analysis on $SIVE. Ayar, Celestial, Lightmatter, Lightelligence are probably valued probably ~$4B-15B+ today. Sivers is ~$2.6B MC and they're likely upstream laser for them all. I'm not even including Poet, TFLN links like Hyperlight/Lightium, or pluggables like Jabil + other undisclosed players in valuation analysis. Or their other segments like CHIPS Act contracts or Apple/Nokia relationships. Or humanoid/physical AI segments with Aeva + others. Retail aren't as familiar with private markets... But these companies are all considered the frontier CPO players, and are growing valuations/scaling rapidly. So, I'd expect $SIVE to command similar if not higher valuations given laser chokepoint premiums. Especially after they pull off M&A to TAM expand revenue. New Blackrock/Vanguard/MSCI/NASDAQ inflow next month helps close that gap over time. But NASDAQ listing is probably what gives Sivers a premium.
-
Sivers为CPO玩家制造架构独特的DFB激光器，是咽喉要道且具高定价权。
光子学是复杂微妙的，用ChatGPT/Gemini会让你忽略其中所有的细微差别： 1. $SIVE实际上是一个咽喉要道，部分也是一个瓶颈。 它之所以是咽喉要道，是因为领先的CPO/光学超大规模玩家都要经过Sivers，很可能是：Ayar、Celestial、Lightmatter、Lightelligence、Poet。 如果你去掉Sivers，你实际上无法制造他们的一些产品，并使路线图延迟数年。 尽管许多是单一/主要来源，但正在朝着多来源方向发展。 至于瓶颈论点：Win Semi是扩大激光生产的瓶颈。 但是……微妙之处在于，当你拥有未来几年的产能分配时，如果玩家们争夺成品激光器的分配，你本身就成为瓶颈的一部分。 这就是人们错过的关于产能分配动态的微妙之处。 这就像说当Kioxia生产全部NAND时，$SNDK不是NAND瓶颈一样。 但当Sandisk拥有最终产出供应控制权时，他们就成为瓶颈+拥有所有定价权。 Sivers在分配的前提下控制CW激光器的产出供应，正如$LITE财报所示，CW激光器目前是瓶颈的，因为每个人似乎都在努力生产EML。 2. 就像大语言模型总是使用破折号一样。 你能看出人们什么时候用AI——当他们总是使用同样的「CW是一个愚蠢的可互换激光器」论点，或者在混淆不同架构后比较「功率」规格时。 这就是为什么你的「分析师」使用AI会一次又一次地犯错。 有CW激光器……然后有Sivers用DFB激光器实现的特定架构设计。 如果你比较$LITE与Sivers的功率规格，孤立来看Lumentum赢了。但它们是完全不同的激光架构。 所有领先的CPO玩家如Ayar，选择$SIVE是因为其高功率、低热、激光阵列的架构原因。$JBL的1.6T LRO还利用Sivers激光器建立了最具戏剧性的护城河之一，他们的炉边谈话中引用了这一点。 如果你认为CW激光器可以和Sumitomo/Furukawa及其他厂商的可互换，可以即插即用……我无话可说。 再次强调：$SIVE为领先的CPO玩家制造架构独特的CW激光器。 3. 我不确定需要说多少次： $SIVE在2024-2025年一直在走开发合同路线。人们使用TTM收入或以前的市销率指标是完全错误的指标，因为2027年才有量产爬坡。 这和$AAOI在2027年上半年量产爬坡一样。 $AEHR在资质认证后量产爬坡。 $LPK在资质认证后量产爬坡。 这只是半导体行业缺少资质认证周期以及对当前财务建模的问题。 至于$LITE的比较（也是我去年长期持有的）： $LITE最初确实是销售激光裸片，然后才收购Cloud Lite和其他下游光学引擎组件。 这就是$SIVE今天的处境——从CPO的激光咽喉要道起步： 人们正基于非常孤立的TAM预测来建模激光收入。与此同时Sivers正在通过并购来扩展TAM预测的收入。 这不是简单的台湾公司组件FAU+爬坡估值建模。 既然激光公司如$LITE、$COHR以向下游扩张使激光更有价值而闻名，然后事后垂直整合（晶圆厂、封装）。 同样，Sivers在这些公司成为十亿美元公司之前就与他们合作过。我有高度信心知道他们知道该收购什么来扩展ELS/光引擎堆叠+可插拔收发器的TAM。 只是很烦人，总有人不理解这些细微差别却对我的长仓指手画脚，说些错误的东西。 我遇到同样的情况说「$AXTI不是瓶颈！InP不需要！中国！」，当时股价是14美元。 现在是140美元。 我遇到同样的情况说「$AAOI要跌50%！」，当时是65美元。或者「AOI管理层有问题」，当时是30美元。 现在是170美元。 我遇到「$SOI没什么新东西」，当时是45美元。 现在是170美元。 我认为我是少数真正理解光子学细微差别的人之一，因为我确实预判了$LITE、$TSEM、Innolight、$AXTI、$AAOI、$SOI，这些在过去一年里表现超过光子学市场和整体市场。 现在我做多$SIVE。
英文原文
Photonics is nuanced and using ChatGPT/Gemini makes you miss all of it: 1. $SIVE is actually a chokepoint and partially a bottleneck. The reason it's a chokepoint is leading CPO/optical hyperscaler players go through Sivers, likely: Ayar. Celestial. Lightmatter. Lightelligence. Poet. If you take out Sivers, you literally can't make some of their products + delay their roadmap by years. As many are sole/primary source but are heading the direction on multi-source. As for the bottleneck argument: Win Semi is the bottleneck for scaling laser production. But... the nuance is when you have capacity allocated for the next few years. You become part of the bottleneck itself if players fight you for allocation of finished lasers. That's the nuance people miss with capacity allocation dynamics. It's like saying $SNDK is not part of the NAND bottleneck when Kioxia makes all of it. But when Sandisk has the ultimate control of output supply, they become the bottleneck + have all the pricing power. Sivers controls output supply of CW lasers given allocations, and as seen with $LITE earnings, CW laser is currently bottlenecked as everyone seems to be stuck producing EMLs. 2. Like how LLMs always uses em-dashes. You can tell when people use AI when they always use the same "CW is a dumb interchangeable laser" argument or compare "power" specs after conflating different architectures. That's why your "analysts" using AI will get this wrong over and over. There's CW lasers... and then there's a specific architectural design that Sivers achieves with DFB lasers. If you compare power specs with $LITE vs. Sivers, Lumentum wins in isolation. But they're completely different laser architectures. All the leading CPO players like Ayar, chose $SIVE for an architectural reason for high power, low thermal, laser arrays. $JBL 1.6T LRO also made one of the most dramatic moats cited by their fireside chat, using Sivers lasers. If you think CW lasers are interchangeable with Sumitomo/Furukawa, and others. And can be plug-and-play... i don't know what to tell you? Again: $SIVE makes architecturally unique CW lasers for leading CPO players. 3. I'm not sure how many times I need to say this: $SIVE for 2024-2025 has been going through development contracts. People using TTM revenue or former P/S metrics are using completely the wrong metrics, when there's volume ramp in 2027. It's the same with $AAOI which volume ramps in H1 2027. $AEHR which volume ramps after qualification. $LPK that volume ramps after qualification. This is just missing qualification cycles in semiconductors and how to model financials currently. As for the $LITE comparisons (which was also my long last year): $LITE literally started off selling laser dies before acquisition of Cloud Lite and other downstream optical engine components. This is where $SIVE is at today with starting off in the laser chokepoint for CPO: People are modeling laser revenue off very isolated TAM projections. Meanwhile Sivers is targeting M&A to expand revenue for TAM projections. This is not a simple component FAU + ramp valuation modeling over with a Taiwanese company. Since Laser companies like $LITE, $COHR are known to downstream expand to make their lasers more valuable, then vertically integrate (fabs, assembly) afterward. Again, Sivers worked with Ayar and these types of companies before they all became billion dollar companies. I have high conviction knowing they know what to acquire down the ELS/optical engine stack + pluggable transceiver for TAM expansion. It's just annoying when I get people who don't understand the nuances backseat commenting wrong things about my longs. I got the same thing about $AXTI is not a bottleneck! InP isn't needed! China! back at $14. Now it's $140 I got the same thing about $AAOI "is going down 50%!" back at $65. or "AOI management is shady at $30". Now it's $170 I got the "there's nothing new with $SOI" back at $45. Now it's $170. I think I'm one of the few who actually understands the nuances with photonics, since I did call out $LITE, $TSEM, Innolight, $AXTI, $AAOI, $SOI, that outperformed both photonics markets and overall markets over the past year. And now I'm long on $SIVE.